Passing the Baton to the 24th Editorial Team

Editorial

Looking into the future: The <i>Journal of Neurophysiology</i>

The Four Rs of the Red Journal: A Progress Report From the New Editorial Team

30 years of the Journal of Hepatology – The flagship journal and the crown-jewel of EASL

A vision for the next phase of JRST

A new era of biotechnology.

So the brief ‘respite’ of summer is over, and we find ourselves plunging, once more towards the abyss of winter bed pressures. Hopefully those of you working at the coalface will find time to browse through the following pages. The production of a third issue in this ‘shortened’ year, following the launch of the Journal in July, is a credit to the hard work of the editorial and publishing teams. I am, as ever, grateful for their support. Next year will see a return to the planned 4-monthly cycle, with issues anticipated in March, July and November. One casualty of the tight schedule has been a minor adjustment to the cycle of reviews – COPD will now appear next Spring. In its place we have included an interesting paper reviewing the management of Neuroleptic Malignant Syndrome and Serotonin Syndrome, submitted by Consultant Psychiatrist David McNamara. Gastrointestinal haemorrhage and atrial fibrillation will be more familiar to readers, while Dr Joanna Girling’s review of the management of medical emergencies in pregnancy is essential reading for any physician working close to a maternity unit. Myasthenia gravis may not be the commonest medical emergency; nonetheless it is important that physicians are able to suspect, diagnose and initiate treatment for this condition. As I mentioned in my last editorial, I am keen to encourage submissions of case reports, audits, and pieces of original research provided they would appeal to a general medical readership. Cases need not be rare conditions, but must contain a clear teaching message for the reader. In future editions case reports will be categorised as ‘Tales of the Unexpected’, and ‘A Case to Remember’ (a memorable case or one with a message that readers should remember in future). The report on page 106 is an example of the latter – an important reminder that a radiological diagnosis of ‘pneumonia’ does not always imply an infective cause. Finally, I would like to thank those of you who have written with feedback following the previous edition of CPD Acute Medicine. We are clearly attempting to appeal to physicians from a broad range of backgrounds, and I hope that all readers find something which appeals to them in the pages which follow. Please feel free to write with your comments on any issue which you would like to share with the editorial team – depending on the response we may consider including a correspondence section in future editions of the journal.

“ in·te·gra·tive, adj., serving to form, coordinate, or blend into a functioning or unified whole ([1][1]).” this single term best describes, in my eyes, the main theme of our journal. I am pleased to introduce to you, the readers of AJP: Regulatory, Integrative and Comparative Physiology ,

The Red Journal's Outstanding Reviewer Awards for 2012

Shining a Spotlight on Photochemistry

After four years of pushing the editorial cart it is time to say farewell. This farewell is said with great satisfaction and gratitude. For this and all the achievements I have to thank the team of editors, associate editors and an army of reviewers. I also thank the president, secretary and board of the International Association for the Study of the Liver for the opportunity and the trust in the editorial team and in myself. The satisfaction stems from the fact that in my opinion we have succeeded in transforming the previous journal, Liver, to our current journal Liver International from a basically pathology-oriented journal into a more general hepatology journal, accommodating both basic and clinical hepatology. The added adjective ‘International’ is not without significance; we have indeed tried to break through the usual continental barriers to become a really global journal. This is where our niche is, the world of Hepatology. We have tried to pay particular attention to the emerging countries without forgetting the more traditional contributions from Europe, Japan and the United States. However, we realize that China and Latin America are emerging as the new scientific superpowers. These are great times with many breakthroughs in particular in the fields of viral hepatitis, metabolic liver disease and liver cancer. In view of the scientific output of so many in so many countries there is place for more than one or two liver journals and this is why I felt comfortable with Liver International and why I am proud of its achievements. For these achievements, I have to particularly thank Mei-Hwei Chang (Asia), Edna Strauss (Latin America), Mike Kew (Africa), Tony Tavill (North America) and the team of associate editors for their superb contributions and efforts to put Liver International on the map and to make Liver International a truly global journal. I also thank the publishers, first Munksgaard and later Blackwell for the excellent support and friendship.

A Note from the Editors&#x0D; &#x0D; We are delighted to welcome you to Volume 10 of the Vanderbilt Undergraduate Research Journal (VURJ), a selection of some of the finest research conducted within the undergraduate community at Vanderbilt University. In the decade since its inception, VURJ has featured over 100 articles in the sciences, humanities, and social sciences. &#x0D; After a brief hiatus in 2014, VURJ came back stronger than ever, boasting our most diverse and selective issue yet. With 73 submissions from students at all four of Vanderbilt’s undergraduate schools, 19 outstanding articles were selected for publication. All submitted manuscripts underwent a rigorous multi-step review process, including two to three rounds of readings by trained peer reviewers, and final selection for publication by VURJ’s team of associate editors. In this issue, you will learn about and explore a diverse selection of topics from arts in trauma therapy to the resurrection of extinct species, an exciting assortment that provides a small glimpse into Vanderbilt’s thriving and dynamic academic community. &#x0D; We encourage you to engage further with this community by contributing some of your own work to our next issue, or by applying to join our team of editors. &#x0D; Happy reading and best wishes,&#x0D; Jelena Belenzada&#x0D; Editor in Chief, 2014-2015&#x0D; &#x0D; Eriny Hanna&#x0D; Editor at Large, 2014-2015

Welcome to the first issue of the ninth volume of the Plant Biotechnology Journal. Building upon the triumphs of 2009, 2010 set new records for the Journal, with a significant increase in manuscript submissions and an increased impact factor of 4.73. As in previous years, this success was hard won by the journal’s fantastic Editorial Team. Now onto even greater heights! In 2010, the Plant Biotechnology Journal continued to speed up the processing of manuscripts such that our average time from submission to first decision now stands at an amazing 15 days. In addition, during 2010, we have tried very hard to fully engage with our reviewers and authors, to improve the feedback received and to ensure that authors feel that, no matter what the final decision, their manuscript has been fairly reviewed and that reviewers understand that their role is essential and their views really count. One thing continues to concern the Editorial Team; it is clear from some of the manuscripts we receive that a significant minority of authors fail to read, or understand, either the Plant Biotechnology Journal’s aims and scope or the instructions to authors. To all authors I say please spend a few minutes examining both our aims and scopes and our instructions to authors. For instance, we continue to find that when we invite a review from a “preferred” reviewer, they are often either unavailable or they are unwilling to undertake the review. Time taken during this process is a significant factor in delaying a number of manuscripts. We therefore strongly urge all authors to check with their preferred reviewers and help to speed up the reviewing process. To emphasize this point, the Editorial Board has decided that from January 2011 we will reject all manuscripts where two or more preferred reviewers refuse or are unable to carry out a review. Authors should note that our statistics show what many people have suspected for a long time; preferred reviewers are no more likely to recommend a manuscript for publication than any other reviewers. During 2010, the Plant Biotechnology Journal received many but accepted fewer manuscripts describing research carried out solely in model species. While the Plant Biotechnology Journal will continue to accept exceptional manuscripts describing novel and potentially useful procedures carried out in model species, the Editorial Team feels that one of the strengths of the Plant Biotechnology Journal is its ability to focus on application. Therefore, during 2011, the journal will continue this trend and focus on crop or model/crop-based research. Hence, manuscripts containing high-quality, but not exceptional, research relating solely to model species will continue to be rejected. Given the aforesaid, the Editorial Team’s advice to any author wishing to submit a manuscript to the Plant Biotechnology Journal is as follows: (i) Only submit exceptional manuscripts to the Plant Biotechnology Journal, as only those manuscripts covering areas described in our aims and scopes and which include novel findings of biological significance in crops or under applied circumstances will be accepted for review, (ii) Provide the Journal with a concise manuscript, in the correct format, and free from grammatical and typographical errors, (iii) Check that your preferred reviewers are able, if requested to do so, to carry out the required review and (iv) Be prepared to meet, in full, the requirements of both the reviewers and the handling editor. By addressing all of these criteria, authors can considerably enhance the chances of their manuscript being accepted and published in the Plant Biotechnology Journal. In 2010, the Editorial Team of the Plant Biotechnology Journal published two special issues covering biofuels (issue 8.3) and molecular farming (issue 8.5). Like the special issue on SNP discovery and high-throughput genotyping published in 2009, these special issues have been highly popular with our readers. In 2011, we intend to publish a fourth special issue on chloroplast biotechnology. The Editorial Team is interested in hearing from you, our readers, about titles for other possible special issues. However, as publishing special issues is time-consuming, the Editorial Team would be interested in hearing from appropriately experienced researchers interested in co-editing specific special issues.

Beginning July 1, 2007, JASN will come under the direction of a new editor-in-chief, Dr. Eric Neilson, and a new editorial team selected by him. Reflecting that changeover, next month JASN will appear in a new style and format with new categories, new features, and new directions. It is time for

My Commitment to Emergency Nurses